There’s no single known cause for myalgic encephalomyelitis, also known as chronic fatigue syndrome. And there’s no cure. That’s why patient partner, Kati Debelic, worked with neuroimaging scientist, Xiaowei Song,…
We will provide support to UBC’s new Immuno-Engineering and Biomanufacturing Hub.
The field of bioprinting holds great promise for human health. Health Research BC awardee, Dr. Stephanie Willerth’s innovative work in this area will ultimately improve health outcomes for people with…
Along with our partners, we are co-funding exceptional research talent who are giving hope to people living with neurological diseases and disorders.
This week, a new organization launches to support researchers across Canada who engage patients in their work: SPOR National Training Entity.
During the pandemic, only 60 percent of people in custody wanted to receive the COVID-19 vaccine. Researchers Sofia Bartlett and Pam Young worked with people who are incarcerated to change…
How does frequent fainting affect people’s daily life? Researchers in the Fraser region worked with patient partners to find out.
The Methods Clusters researched the “how” of patient-oriented research for 5 years. What did we learn? What questions remain? Amber Hui, Stirling Bryan and Danielle Lavallee discuss.
Patients are often overlooked when designing health research projects. Researchers in BC wanted to change that.
Renewed federal and provincial funding in health research continues to engage patients and improve care for people in BC.
JDRF Canada is proud to partner with Health Research BC and provide support to Dr. Tricia Tang through our HP-I award.
Health researchers in BC now have access to a suite of online educational modules that help engage diverse people in health research.
BC SUPPORT Unit team members gathered in Vancouver on June 28 and 29 from all parts of the province.
Dr. Eli Puterman and his team are collaborating with Providence Health Care, to refine their research to specifically support health care workers.
The IMPACT-AD study is designed to specifically address barriers to uptake and use of Alzheimer’s disease testing in the Canadian health care system.